Chrysos Corp. Ltd. · ASX:C79
Chrysos — Shareholder Meeting (November 2026)
17 slides from Chrysos's shareholder meeting presentation, Nov 19, 2026
Slide 1: Faster, more accurate gold analysis
rsonal use only Faster, more accurate gold analysis 2026 Pre-AGM Trading Update 19 November 2026 Dirk Treasure, Managing Director and CEO
Slide 2: Important notice
Important notice rsonal use only The material in this presentation has been prepared by Chrysos Corporation Limited (ASX: C79) (“Chrysos” or the “Group") and is general background information about Chrysos’ current activities as at the date of this presentation. The information is given in summary f
Slide 3: The Chrysos investment proposition
The Chrysos investment proposition PhotonAssayTM is the mining industry’s most innovative assaying solution rsonal use only Delivering faster, safer, more accurate and environmentally-friendly gold analysis Non-discretionary spend Competitive fee-per-sample model for miners Long-term contracts Stron
Slide 4: Financial and operating highlights
Financial and operating highlights Strong start to FY27 supported by industry activity rsonal use only $36.7m 4.91m Unaudited Total Revenue (July to October 2026)1 PhotonAssayTM Samples (July to October 2026) • +27% growth versus PCP • +43% growth versus PCP • MMAP Revenue of $22.6m (+7% PCP), AAC R
Slide 5: PhotonAssay sample volumes
PhotonAssayTM sample volumes Continued conversion to PhotonAssayTM and strong utilisation of our deployed fleet rsonal use only PhotonAssayTM Samples Analysed (rolling 12 months) Activity Commentary ■ Sustained PhotonAssayTM demand, with volumes exceeding 1m samples 1,400,000 every month since March
Slide 6: Executing on our global PhotonAssay roll-out
Executing on our global PhotonAssayTM roll-out Strengthening relationships with key miners and laboratories rsonal use only 51 Units Deployed1 YTD Activity (as at 19 November 2026) Six units deployed in FY27 BV – Kalgoorlie, Australia ALS – Rouyn Noranda, Canada ALS – Surrey, Canada Aurenn
Slide 7: PhotonAssay deployments
PhotonAssayTM deployments Global fleet supporting future growth rsonal use only Total PhotonAssayTM Units Deployed PhotonAssayTM Units Contracted PhotonAssayTM Units 59 → 66 +7 46 → 51 +5 87 → 97 + 10 Units manufactured since Aug 2026 Results Net of the Mali unit which has been demobilised From Aug
Slide 8: Doubling our deployed fleet by FY29
Doubling our deployed fleet by FY29 Contracted pipeline underpins our target of 90 deployed PhotonAssay units by the end of FY29 rsonal use only PhotonAssay Units Deployed (end of financial year) Pathway to 90 Units 100 ■ Manufacturing cadence increased to 18 units per year, supporting the pathway t
Slide 9: Financial highlights
Financial highlights Record sample volumes continue to underpin revenue rsonal use only FY27 Guidance ■ Reaffirmed FY27 guidance1 of: ■ FY27 Revenue range of $108m to $118m ■ FY27 EBITDA range of $35m to $42m Cash & Debt Position ■ Cash on hand $19.5m ■ $200m debt facility in place, of which $80m ha
Slide 10: Thank you
Thank you rsonal use only For more information, please visit chrysoscorp.com or contact us at investors@chrysoscorp.com
Slide 11: Appendix: About Chrysos
rsonal use only Appendix: [Insert] About Chrysos
Slide 12: Our commercialisation journey
Our commercialisation journey The outcome of 20+ years of research and development rsonal use only Newmont MSA To use International PhotonAssayTM Prototype Complete JORC and NI43-101 New Customer across its deployment continues 1st PhotonAssayTM Max unit Companies cite PhotonAssayTM Announcements Es
Slide 13: PhotonAssay technology
PhotonAssayTM technology Efficient, effective and environmentally-friendly minerals analysis rsonal use only Step 1 Step 2 Step 3 The crushed sample Automated high-energy X-ray analysis Automated reporting (2–3 mm) is loaded activates and detects gold atoms into jars and scanned Sample can be retain
Slide 14: Every gold mine runs on assay data
Every gold mine runs on assay data Almost every Reserve or Resource is defined by either fire assay or PhotonAssay rsonal use only Grade Exploration Stockpile Plant Tailings Product control Faster decisions Representative data Process optimisation Recovery opportunity Results while the shift Larger
Slide 15: No level of lead exposure is acceptable
No level of lead exposure is acceptable PhotonAssay removes lead risks from the assay lab rsonal use only Improved OH&S for operators ESG advantages PhotonAssayTM improves OH&S outcomes through the elimination of A 2025 GHD study at SGS Kalgoorlie identified three key environmental advantages of Pho
Slide 16: Simple to adopt, protected returns
Simple to adopt, protected returns Each PhotonAssay unit is owned, leased and maintained by Chrysos rsonal use only Customer impact Chrysos benefit Capital stays in the mine: no upfront Take-or-pay floor: 71% of FY26 revenue spend; the unit is leased, not bought (~A$1.43m3 per unit p.a.) No obsolesc
Slide 17: Experienced leadership team
Experienced leadership team Supported by a well-respected and tenured board rsonal use only Senior leadership team Board of Directors Dirk Treasure Rob Adamson – appointed June 2016 Kerry Gleeson – appointed July 2021 Founding CEO & Managing Director Founder & Non-Executive Chairman Non-Executive Di